Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates

Background Mycobacterium avium subsp. hominissuis (MAH) is an emerging opportunistic human pathogen. It can cause pulmonary infections, lymphadenitis and disseminated infections in immuno-compromised patients. In addition, MAH is widespread in the environment, since it has been isolated from water,...

Full description

Bibliographic Details
Main Authors: Andrea Sanchini, Flavia Dematheis, Torsten Semmler, Astrid Lewin
Format: Article
Language:English
Published: PeerJ Inc. 2017-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/2833.pdf
_version_ 1797425005714210816
author Andrea Sanchini
Flavia Dematheis
Torsten Semmler
Astrid Lewin
author_facet Andrea Sanchini
Flavia Dematheis
Torsten Semmler
Astrid Lewin
author_sort Andrea Sanchini
collection DOAJ
description Background Mycobacterium avium subsp. hominissuis (MAH) is an emerging opportunistic human pathogen. It can cause pulmonary infections, lymphadenitis and disseminated infections in immuno-compromised patients. In addition, MAH is widespread in the environment, since it has been isolated from water, soil or dust. In recent years, knowledge on MAH at the molecular level has increased substantially. In contrast, knowledge of the MAH metabolic phenotypes remains limited. Methods In this study, for the first time we analyzed the metabolic substrate utilization of ten MAH isolates, five from a clinical source and five from an environmental source. We used BIOLOG Phenotype MicroarrayTM technology for the analysis. This technology permits the rapid and global analysis of metabolic phenotypes. Results The ten MAH isolates tested showed different metabolic patterns pointing to high intra-species diversity. Our MAH isolates preferred to use fatty acids such as Tween, caproic, butyric and propionic acid as a carbon source, and L-cysteine as a nitrogen source. Environmental MAH isolates resulted in being more metabolically active than clinical isolates, since the former metabolized more strongly butyric acid (p = 0.0209) and propionic acid (p = 0.00307). Discussion Our study provides new insight into the metabolism of MAH. Understanding how bacteria utilize substrates during infection might help the developing of strategies to fight such infections.
first_indexed 2024-03-09T08:09:45Z
format Article
id doaj.art-aeac8e8002d24eaea75518b1eaa84674
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T08:09:45Z
publishDate 2017-01-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-aeac8e8002d24eaea75518b1eaa846742023-12-02T23:30:40ZengPeerJ Inc.PeerJ2167-83592017-01-015e283310.7717/peerj.2833Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolatesAndrea Sanchini0Flavia Dematheis1Torsten Semmler2Astrid Lewin3Division 16, Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, Berlin, GermanyInstitute of Microbiology and Epizootics, Free University Berlin, Berlin, GermanyNG 1 Microbial Genomics, Robert Koch Institute, Berlin, GermanyDivision 16, Mycotic and Parasitic Agents and Mycobacteria, Robert Koch Institute, Berlin, GermanyBackground Mycobacterium avium subsp. hominissuis (MAH) is an emerging opportunistic human pathogen. It can cause pulmonary infections, lymphadenitis and disseminated infections in immuno-compromised patients. In addition, MAH is widespread in the environment, since it has been isolated from water, soil or dust. In recent years, knowledge on MAH at the molecular level has increased substantially. In contrast, knowledge of the MAH metabolic phenotypes remains limited. Methods In this study, for the first time we analyzed the metabolic substrate utilization of ten MAH isolates, five from a clinical source and five from an environmental source. We used BIOLOG Phenotype MicroarrayTM technology for the analysis. This technology permits the rapid and global analysis of metabolic phenotypes. Results The ten MAH isolates tested showed different metabolic patterns pointing to high intra-species diversity. Our MAH isolates preferred to use fatty acids such as Tween, caproic, butyric and propionic acid as a carbon source, and L-cysteine as a nitrogen source. Environmental MAH isolates resulted in being more metabolically active than clinical isolates, since the former metabolized more strongly butyric acid (p = 0.0209) and propionic acid (p = 0.00307). Discussion Our study provides new insight into the metabolism of MAH. Understanding how bacteria utilize substrates during infection might help the developing of strategies to fight such infections.https://peerj.com/articles/2833.pdfMycobacterium aviumBiologOmniLog®MetabolismPhenotype microarray
spellingShingle Andrea Sanchini
Flavia Dematheis
Torsten Semmler
Astrid Lewin
Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
PeerJ
Mycobacterium avium
Biolog
OmniLog®
Metabolism
Phenotype microarray
title Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
title_full Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
title_fullStr Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
title_full_unstemmed Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
title_short Metabolic phenotype of clinical and environmental Mycobacterium avium subsp. hominissuis isolates
title_sort metabolic phenotype of clinical and environmental mycobacterium avium subsp hominissuis isolates
topic Mycobacterium avium
Biolog
OmniLog®
Metabolism
Phenotype microarray
url https://peerj.com/articles/2833.pdf
work_keys_str_mv AT andreasanchini metabolicphenotypeofclinicalandenvironmentalmycobacteriumaviumsubsphominissuisisolates
AT flaviadematheis metabolicphenotypeofclinicalandenvironmentalmycobacteriumaviumsubsphominissuisisolates
AT torstensemmler metabolicphenotypeofclinicalandenvironmentalmycobacteriumaviumsubsphominissuisisolates
AT astridlewin metabolicphenotypeofclinicalandenvironmentalmycobacteriumaviumsubsphominissuisisolates